Braidwell LP Dyne Therapeutics, Inc. Transaction History

Braidwell LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$6.62 - $13.64 $7.06 Million - $14.5 Million	-1,066,161 Reduced 58.52%	755,811 $10.1 Billion
Q3 2023 Nov 14, 2023	BUY	$8.6 - $12.18 $3.82 Million - $5.41 Million	444,100 Added 32.23%	1,821,972 $16.3 Billion
Q1 2023 May 15, 2023	BUY	$10.88 - $15.0 $6.8 Million - $9.37 Million	624,727 Added 82.95%	1,377,872 $15.9 Billion
Q4 2022 Feb 14, 2023	BUY	$9.37 - $13.8 $7.06 Million - $10.4 Million	753,145 New	753,145 $8.73 Billion

207

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $765M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

Stay updated on Braidwell LP with notifications on news.